Prevention of Hepatocellular Carcinoma: Potential Targets, Experimental Models, and Clinical Challenges

Publisher： Bentham Science Publishers

E-ISSN： 1873-5576|12|9|1129-1159

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.12, Iss.9, 2012-11, pp. : 1129-1159

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

mTOR as a Potential Target for the Prevention and Treatment of Hepatocellular Carcinoma

By  

Current Cancer Drug Targets, Vol. 12, Iss. 9, 2012-11 ,pp. : 1045-1061

Bentham Science Publishers

Access to resources Recommend Favorite

Dietary Phytochemicals in the Chemoprevention and Treatment of Hepatocellular Carcinoma: In Vivo Evidence, Molecular Targets, and Clinical Relevance

By  

Current Cancer Drug Targets, Vol. 12, Iss. 9, 2012-11 ,pp. : 1191-1232

Bentham Science Publishers

Access to resources Recommend Favorite

Inhibition of apoptosis: potential clinical targets

By Nuttall M.E.   Levy M.A.   James M.F.   Winkler J.D.  

Expert Opinion on Emerging Drugs, Vol. 3, Iss. 1, 1998-06 ,pp. : 317-333

Informa Healthcare

Access to resources Recommend Favorite

Angiogenesis in Hepatocellular Carcinoma: A Potential Target for Chemoprevention and Therapy

By  

Current Cancer Drug Targets, Vol. 12, Iss. 9, 2012-11 ,pp. : 1095-1118

Bentham Science Publishers

Access to resources Recommend Favorite

Sorafenib: activity and clinical application in patients with hepatocellular carcinoma

By Guan Yong-Song   He Qing  

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 2, 2011-02 ,pp. : 303-313

Informa Healthcare

Access to resources Recommend Favorite